USAID
Measles vaccination is a critical public health intervention aimed at preventing measles, a highly contagious viral disease.
2 pages

Abstract
The measles vaccine is a potent vaccine that requires proper handling and administration to ensure its effectiveness. Vaccinators at health facility level play a crucial role in conducting measles vaccination sessions, adhering to strict guidelines and protocols to ensure the safety and efficacy of the vaccine. The measles vaccine is typically stored in a functional refrigerator with a temperature range of +2 to +8°C, as indicated by the fridge tag. Before administering the vaccine, the vaccinator must observe and record the refrigerator temperature to ensure it is within the acceptable range. The vaccine vial monitor (VVM) is also checked to verify that the vaccine has not been exposed to temperatures outside the acceptable range. Upon arrival of a client or clients, the vaccinator prepares the vaccine by taking it out of the refrigerator and observing the VVM, expiration date, and instructions. The vaccine diluents are then taken from the refrigerator and observed to ensure they match the vaccine's batch number. The reconstitution syringe is used to draw the diluents and reconstitute the vaccine, which is then placed in the vaccine carrier. The vaccinator records the time of reconstitution, as the vaccine must be discarded after six hours. The vaccinator then explains the vaccine's name, the disease it prevents, safety and benefits, side effects, and proper handling to the caretaker. The child is prepared for vaccination, and the vaccinator takes an AD syringe 0.5 ml to draw the reconstituted vaccine from the vial. The vaccine is administered subcutaneously on the left shoulder, and the reconstituted vaccine is placed back in the refrigerator. The syringe and needle are disposed of in a safety box. After vaccination, the vaccinator gives final instructions to the caretaker on home management of minor side effects, thanks and congratulates them, and informs them of the date for the next visit. The child is observed for 30 minutes for any minor side effects, and the caretaker is allowed to leave with the child.
Connected topics
Classification
USAID DEC